Neuphoria Therapeutics Inc. Operating Lease Right-of-Use Assets
Neuphoria Therapeutics Inc. (NEUP) had Operating Lease Right-of-Use Assets of $75.22 thousand as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-09-18
- 2025-09-30: Operating Lease, Right-of-Use Asset $75.22K.
- 2025-06-30: Operating Lease, Right-of-Use Asset $102.61K.
- 2025-03-31: Operating Lease, Right-of-Use Asset $125.21K.
- 2024-12-31: Operating Lease, Right-of-Use Asset $150.52K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-09-30 | $75.22K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $102.61K 10-K · filed 2026-09-18 |
| 2025-03-31 | $125.21K 10-Q · filed 2025-05-20 |
| 2024-12-31 | $150.52K 10-Q · filed 2025-02-14 |
| 2024-09-30 | $197.45K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $216.97K 10-K · filed 2025-09-29 |
| 2023-06-30 | $330.48K 10-K · filed 2024-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |